Former Interim Chief Financial Officer (12) · Clover Health Investments, Corp. (CLOV)

Mark Herbers

A named executive officer of Clover Health Investments in every fiscal year CompBrief holds from FY2021 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,249,500

Salary $0Stock awards $0

FY2021: $1,034,886

5th of 5 named executive officers at Clover Health Investments by FY2022 total.

6 named officers on file for Clover Health Investments, FY2022

Mark Herbers’s pay file — $29

  • 2 fiscal years of pay, line by line
  • CLOV’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Clover Health Investments’s whole pay program stands against its peers

  • Clover Health Investments’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CLOV→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2023 (DEF 14A).

Free

Get Mark Herbers’s full pay file as a PDF — free

More than this page: up to 10 years of Mark’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Mark Herbers compensation by year

Clover Health Investments Summary Compensation Table · all 2 fiscal years held
In US dollars, as Clover Health Investments reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022
Salary$0$0
Bonus$0$0
Stock awards$0$0
Option awards$0$0
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$1,034,886$1,249,500
Total$1,034,886$1,249,500

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Clover Health Investments, Corp. DEF 14A filed April 26, 2023, accession 0001801170-23-000031, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Clover Health Investments, Corp. filed document, accession 0001801170-23-000031. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2023.

$1.0M
$1.2M
FY21
FY22
All other

Clover Health Investments’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Scott LefflerChief Financial Officer$13,529,434
Andrew ToyPresident (9)$10,171,476
Joseph MartinGeneral Counsel (10)$8,903,471
Brady PriestChief Executive Officer of Home Care$4,534,758
Mark Herbers · this pageFormer Interim Chief Financial Officer (12)$1,249,500
Vivek GaripalliChief Executive Officer (7)—

The full Clover Health Investments compensation record

free company brief

This page is one person within Clover Health Investments's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Clover Health Investments proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Clover Health Investments's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Mark Herbers's compensation dossier · One-time report. No refunds.